Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

T Cell Types and Functions

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Ocular toxoplasmosis in Latin American and European patients: clinical characteristics, visual outcomes, and recurrence patterns.

Journal of ophthalmic inflammation and infection·2026

Same author

Long-Term Evolution of Treatment Outcomes with Once-Daily Ciclosporin A 0.1% Cationic Emulsion in Patients with Dry Eye Disease and Severe Keratitis.

Ophthalmology and therapy·2026

Same author

Immune Checkpoint Inhibitor-Associated Uveitis Treated with the 0.19 Mg Fluocinolone Acetonide Intravitreal Implant: Clinical Outcomes in a Retrospective Case-Series.

Ocular immunology and inflammation·2026

Same author

The role of interleukin-6 in diabetic retinal disease: pathophysiology and therapeutic targeting.

Frontiers in immunology·2026

Same author

Ultra-widefield retinal imaging for early detection of asymptomatic cytomegalovirus retinitis after allogeneic hematopoietic stem cell transplantation: a prospective pilot feasibility study.

Journal of ophthalmic inflammation and infection·2026

Same author

Decellularized Aged Bruch's Membrane Confers Unique Biochemical Cues to Retinal Pigment Epithelium for In Vitro Modeling of Age-Related Macular Degeneration.

Aging cell·2026

Search research articles

Related Experiment Video

Updated: Feb 25, 2026

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model

Published on: January 12, 2022

Targeting interleukin-6 in autoimmune uveitis.

Marina Mesquida¹, Blanca Molins², Víctor Llorenç³

¹Uveitis Unit, Institut Clinic d'Oftalmologia, Hospital Clinic de Barcelona, Universitat de Barcelona, Spain; Fundació Clínic per a la Recerca Biomèdica, IDIBAPS, Barcelona, Spain.

Autoimmunity Reviews

|August 6, 2017

Summary

Interleukin-6 (IL-6) is a key cytokine implicated in inflammation and various diseases. Targeting IL-6 signaling, particularly with monoclonal antibodies like tocilizumab, shows promise for treating inflammatory eye conditions.

Keywords:

Autoimmune uveitis Biologic therapy Interleukin-6 Tocilizumab

More Related Videos

Induction of Ocular Surface Inflammation and Collection of Involved Tissues

Induction of Ocular Surface Inflammation and Collection of Involved Tissues

Published on: August 4, 2022

Primed Mycobacterial Uveitis PMU as a Model for Post-Infectious Uveitis

Primed Mycobacterial Uveitis PMU as a Model for Post-Infectious Uveitis

Published on: December 17, 2021

Related Experiment Videos

Last Updated: Feb 25, 2026

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model

Published on: January 12, 2022

Induction of Ocular Surface Inflammation and Collection of Involved Tissues

Induction of Ocular Surface Inflammation and Collection of Involved Tissues

Published on: August 4, 2022

Primed Mycobacterial Uveitis PMU as a Model for Post-Infectious Uveitis

Primed Mycobacterial Uveitis PMU as a Model for Post-Infectious Uveitis

Published on: December 17, 2021

Area of Science:

Immunology
Ophthalmology
Molecular Biology

Background:

Interleukin-6 (IL-6) is a pleiotropic cytokine crucial for immune responses, inflammation, and tissue homeostasis.
Dysregulated IL-6 production is linked to systemic autoimmune diseases, chronic conditions, and cancer.
Elevated IL-6 levels are observed in ocular fluids of patients with diabetic macular edema, retinal vein occlusion, and uveitis.

Purpose of the Study:

To review the fundamental biology of IL-6 and its pathological role in immune-mediated diseases.
To focus on the specific involvement of IL-6 in inflammatory eye diseases.
To provide an overview of ongoing clinical trials for novel anti-IL-6 therapies.

Main Methods:

Literature review of IL-6 biology and its role in disease.
Analysis of studies investigating IL-6 in ocular inflammatory conditions.
Survey of current clinical trials involving IL-6 pathway inhibitors.

Main Results:

IL-6 plays a significant role in inducing acute-phase proteins, immune cell trafficking, and T cell differentiation.
Tocilizumab, an IL-6 receptor antagonist, is approved for rheumatoid arthritis and shows efficacy in uveitis.
Numerous anti-IL-6 therapies are progressing through clinical trials for various immune-mediated disorders.

Conclusions:

IL-6 is a critical mediator in inflammatory eye diseases, making it a therapeutic target.
Anti-IL-6 therapies, including monoclonal antibodies, offer potential new treatment options for ocular inflammatory conditions.
Further research and clinical trials are essential to establish the full potential of IL-6 targeted therapies in ophthalmology.